Loading company
PERRIGO Co plc
PRGO · NYSE · Healthcare · Drug Manufacturers Specialty and Generic
Next earnings: November 4, 2026
$14.98-0.7%Sep 29 close
- 1M
- +3.5%
- 6M
- +59.5%
- 1Y
- -28.0%
- 5Y
- -58.5%
PRGO · NYSE · Healthcare · Drug Manufacturers Specialty and Generic
Next earnings: November 4, 2026
$14.98-0.7%Sep 29 close
PERRIGO Co plc is scheduled to report next on November 4, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 27, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 27, 2026 | 3 months toJun 28, 2025 | Change |
|---|---|---|---|
| Total Revenue | $1B | $1.1B | -3.17% |
| Profit | $74.5M | -$8.4M | +986.90% |
| Profit per share | $0.53 | -$0.06 | +983.33% |
| Free Cash Flow | $68.3M | $56.7M | +20.46% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
“), a leading provider of Consumer Self-Care Products , today announced financial results from continuing operations for the second quarter ended June 27, 2026. “We continued to execute our Three-S plan in the second quarter, strengthening areas of the business within our control, improving operational performance, streamlining our portfolio, and further reducing debt,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land after the close or before the open, so the move is the session that follows.
Perrigo Company plc (NYSE: PRGO) is a leading provider of Consumer Self-Care Products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from PERRIGO Co plc’s Item 2.02 8-K filed August 5, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
PERRIGO Co plc has no earnings call transcript available.